Skip to main content
Clinical Trials/NCT03462472
NCT03462472
Unknown
Not Applicable

The Acute Effects of Leg Heating and Transcutaneous Electrical Nerve Stimulation on Leg Blood Flow and Functional Capacity in Those With Peripheral Arterial Disease

Salisbury University1 site in 1 country10 target enrollmentNovember 15, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peripheral Arterial Disease
Sponsor
Salisbury University
Enrollment
10
Locations
1
Primary Endpoint
Distance walked during six-minute walk test
Last Updated
8 years ago

Overview

Brief Summary

Peripheral arterial disease (PAD) is characterized by poor circulation in the lower extremities that often provokes claudication (leg pain, numbness, and heaviness) with physical exertion. The aim of this research protocol is to determine the effect of two non-invasive treatment modalities on leg blood flow and exercise capacity in those with PAD. Specifically, we are measuring popliteal artery blood flow (Doppler ultrasound), toe oxygen saturation, ankle-brachial index (ABI), and 6-minute walking distance (6MWD) in men and women who have intermittent claudication (Fontaine Stage II; Rutherford Category 1-2) in response to 15 or 45 minutes of lower limb heating and transcutaneous electrical nerve stimulation (TENS).

Registry
clinicaltrials.gov
Start Date
November 15, 2015
End Date
June 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Intermittent claudication (Fontaine Stage II)
  • Resting ankle-brachial index (ABI) \< 0.90
  • Ability to walk \> 60 meters in six minutes

Exclusion Criteria

  • Body mass index (BMI) \> 35 kg/m2
  • Severe exercise limitations (more than PAD) due to co-morbidity
  • Taking illegal/recreational drugs
  • Uncontrolled hypertension (\>180/100 mmHg)
  • Severe peripheral neuropathy
  • Foot ulcers
  • Pregnant or breast feeding

Outcomes

Primary Outcomes

Distance walked during six-minute walk test

Time Frame: 35 minutes post-intervention/control

Distance walked during a self-paced six-minute walk

Secondary Outcomes

  • Time/distance to claudication during six-minute walk(35 minutes following each intervention and control period)
  • Ankle brachial index (ABI)(Pre-intervention baseline and 20 minutes post-intervention/control)
  • Toe oxygen saturation(Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control)
  • Popliteal artery blood flow(Pre-intervention baseline; 10, 20, and 30 minutes post-intervention/control)

Study Sites (1)

Loading locations...

Similar Trials